Short Interest in Escalon Medical Corp. (OTCMKTS:ESMC) Increases By 3,200.0%

Escalon Medical Corp. (OTCMKTS:ESMCGet Free Report) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 3,300 shares, a growth of 3,200.0% from the March 31st total of 100 shares. Based on an average daily trading volume, of 800 shares, the days-to-cover ratio is currently 4.1 days.

Escalon Medical Stock Performance

OTCMKTS:ESMC opened at $0.24 on Friday. Escalon Medical has a one year low of $0.07 and a one year high of $0.39. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.64 and a quick ratio of 1.09. The company’s 50-day simple moving average is $0.22 and its 200 day simple moving average is $0.22. The firm has a market capitalization of $1.78 million, a P/E ratio of 6.00 and a beta of -0.50.

Escalon Medical (OTCMKTS:ESMCGet Free Report) last issued its earnings results on Wednesday, February 14th. The medical equipment provider reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $2.87 million during the quarter. Escalon Medical had a return on equity of 39.40% and a net margin of 3.85%.

About Escalon Medical

(Get Free Report)

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea.

Read More

Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.